ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
4,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
5,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
6,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
7,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
8,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
8,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
10,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
10,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
12,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
13,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
14,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
15,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
16,1,Anticoagulation drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
16,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
16,3,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
17,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
17,2,Rash papulosquamous,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
18,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
19,1,Headache,Headaches NEC,Headaches,Nerv,N
19,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
21,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
22,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
23,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
24,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
24,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
25,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
25,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
26,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
27,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
28,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
29,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
29,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
29,3,Headache,Headaches NEC,Headaches,Nerv,N
29,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
30,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
31,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
31,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
32,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
33,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
34,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
35,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
35,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
37,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
38,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
39,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
40,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
41,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
42,1,Dysphoria,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
43,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
44,1,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
45,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
46,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
47,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
49,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
49,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
50,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
51,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
52,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
53,1,Headache,Headaches NEC,Headaches,Nerv,N
54,1,Headache,Headaches NEC,Headaches,Nerv,N
55,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
56,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
56,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
56,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
57,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
57,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
57,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
58,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
58,2,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
59,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
59,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
59,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
60,1,Bundle branch block left,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
61,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
61,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
62,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
62,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
63,1,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
64,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
64,2,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
64,3,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
64,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
64,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
65,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
66,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
66,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
67,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
67,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
68,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
68,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
68,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
69,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
70,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
71,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
72,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
73,1,Ventricular arrhythmia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
74,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
75,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
76,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
77,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
77,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
77,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
77,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
77,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
78,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
78,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
78,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
79,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
79,2,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,Y
80,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
81,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
82,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
82,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
83,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
84,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
85,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
86,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
86,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
87,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
88,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
88,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
88,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
89,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
90,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
91,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
92,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
93,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
94,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
95,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
96,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
96,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
97,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
97,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
97,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
97,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
97,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
98,1,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
99,1,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
100,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
101,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
102,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
102,2,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
103,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
103,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
104,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
105,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
105,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,Y
105,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
105,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
106,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
107,1,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
108,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
109,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
110,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
110,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
111,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
112,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
112,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
113,1,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
